logo

Exhibiting at VIV Asia 2025

3-49102
Bangkok
12 Mar - 14 Mar, 2025

Product Offerings

Products:

Ruminants: Injectable Suspension, Injectable Solution, Uterine Perfusion

Swine: Intra-mammary, Powder, Disinfectant

Poultry: Pour on, Spot on, Ointment

Aquatic: Spray

Pets: Feed Additives

Eastern Along Pharmaceutical Co., Ltd. is a leading pharmaceutical manufacturer specializing in veterinary medicine and animal health solutions. Established in Foshan, China, the company has built a strong reputation for its high-quality pharmaceutical products catering to the livestock, poultry, aquatic, and pet industries. With an extensive range of formulations, Eastern Along Pharmaceutical serves global markets with a commitment to innovation, compliance, and efficacy.

Core Business and Specialization

Eastern Along Pharmaceutical focuses on research, development, and production of veterinary medicines, particularly in the following categories:

  • Ruminant Health Solutions: Injectable suspensions, injectable solutions, and uterine perfusions.
  • Swine Health Products: Intramammary solutions, powders, and disinfectants.
  • Poultry Medications: Pour-on and spot-on treatments, as well as ointments.
  • Aquatic Healthcare: Spray applications for disease management in aquaculture.
  • Pet Nutrition and Care: Feed additives for optimal pet health.

The company’s R&D team collaborates with industry experts to continuously improve product efficacy and expand its portfolio. Their products undergo rigorous quality control procedures to meet international safety and regulatory standards.

Market Reach and Export Performance

Eastern Along Pharmaceutical has a strong global presence, supplying veterinary medicines to multiple countries across Asia, Africa, the Middle East, and Latin America. The company actively exports its pharmaceutical products to over 30 countries, ensuring compliance with international regulatory authorities such as GMP (Good Manufacturing Practices) certification.

According to import-export trade databases, Eastern Along Pharmaceutical has recorded hundreds of international shipments, with key markets in Southeast Asia, Latin America, and Africa. The company has successfully positioned itself as a reliable supplier for large-scale livestock farms, veterinary clinics, and agricultural enterprises.

Certifications and Compliance

Eastern Along Pharmaceutical is committed to adhering to global pharmaceutical manufacturing standards. The company holds multiple certifications, including:

  • GMP Certification – Ensuring quality control in production.
  • ISO Standards Compliance – Meeting international safety and efficacy guidelines.
  • Veterinary Drug Registration – Approved for export and local sales in various markets.

Manufacturing Capabilities and Infrastructure

The company's production facility in Foshan is equipped with state-of-the-art manufacturing lines, including:

  • Automated production and filling systems to maintain precision in formulations.
  • Quality control laboratories for microbiological and chemical testing.
  • Research and development facilities focused on innovation in animal healthcare.

Strategic Advantages

Eastern Along Pharmaceutical differentiates itself with:

  1. Diverse Product Portfolio: Offering solutions for multiple livestock categories.
  2. International Reach: Strong presence in global veterinary medicine markets.
  3. Regulatory Expertise: Compliance with GMP and international veterinary health standards.
  4. Innovation-Driven R&D: Focus on continuous product development and improvement.
  5. Reliable Supply Chain: Ensuring consistent product availability for clients worldwide.

Major Achievements

  • Successfully expanded into over 30 international markets, supplying veterinary products to large-scale agricultural enterprises.
  • Consistently meeting GMP and ISO certification standards, reinforcing product credibility.
  • Established a strong distribution network that ensures efficient product availability in key markets.

Eastern Along Pharmaceutical Co., Ltd. continues to strengthen its global presence by expanding its product line, enhancing manufacturing efficiency, and ensuring compliance with evolving veterinary pharmaceutical regulations.